Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal oxytocin spray for methadone discontinuation in opioid-dependent patients
IRCT20191003044971N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in opioid use disorder (OUD), sponsored by Tehran University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20191003044971N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191003044971N1.